Skip to main content
Top
Published in: BMC Cancer 1/2011

Open Access 01-12-2011 | Research article

HNF1α inhibition triggers epithelial-mesenchymal transition in human liver cancer cell lines

Authors: Laura Pelletier, Sandra Rebouissou, Danijela Vignjevic, Paulette Bioulac-Sage, Jessica Zucman-Rossi

Published in: BMC Cancer | Issue 1/2011

Login to get access

Abstract

Background

Hepatocyte Nuclear Factor 1α (HNF1α) is an atypical homeodomain-containing transcription factor that transactivates liver-specific genes including albumin, α-1-antitrypsin and α- and β-fibrinogen. Biallelic inactivating mutations of HNF1A have been frequently identified in hepatocellular adenomas (HCA), rare benign liver tumors usually developed in women under oral contraceptives, and in rare cases of hepatocellular carcinomas developed in non-cirrhotic liver. HNF1α-mutated HCA (H-HCA) are characterized by a marked steatosis and show activation of glycolysis, lipogenesis, translational machinery and mTOR pathway. We studied the consequences of HNF1α silencing in hepatic cell lines, HepG2 and Hep3B and we reproduced most of the deregulations identified in H-HCA.

Methods

We transfected hepatoma cell lines HepG2 and Hep3B with siRNA targeting HNF1α and obtained a strong inhibition of HNF1α expression. We then looked at the phenotypic changes by microscopy and studied changes in gene expression using qRT-PCR and Western Blot.

Results

Hepatocytes transfected with HNF1α siRNA underwent severe phenotypic changes with loss of cell-cell contacts and development of migration structures. In HNF1α-inhibited cells, hepatocyte and epithelial markers were diminished and mesenchymal markers were over-expressed. This epithelial-mesenchymal transition (EMT) was related to the up regulation of several EMT transcription factors, in particular SNAIL and SLUG. We also found an overexpression of TGFβ1, an EMT initiator, in both cells transfected with HNF1α siRNA and H-HCA. Moreover, TGFβ1 expression is strongly correlated to HNF1α expression in cell models, suggesting regulation of TGFβ1 expression by HNF1α.

Conclusion

Our results suggest that HNF1α is not only important for hepatocyte differentiation, but has also a role in the maintenance of epithelial phenotype in hepatocytes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Courtois G, Morgan JG, Campbell LA, Fourel G, Crabtree GR: Interaction of a liver-specific nuclear factor with the fibrinogen and alpha 1-antitrypsin promoters. Science. 1987, 238 (4827): 688-692. 10.1126/science.3499668.CrossRefPubMed Courtois G, Morgan JG, Campbell LA, Fourel G, Crabtree GR: Interaction of a liver-specific nuclear factor with the fibrinogen and alpha 1-antitrypsin promoters. Science. 1987, 238 (4827): 688-692. 10.1126/science.3499668.CrossRefPubMed
2.
go back to reference Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL, Volkert TL, Schreiber J, Rolfe PA, Gifford DK, et al: Control of pancreas and liver gene expression by HNF transcription factors. Science. 2004, 303 (5662): 1378-1381. 10.1126/science.1089769.CrossRefPubMedPubMedCentral Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL, Volkert TL, Schreiber J, Rolfe PA, Gifford DK, et al: Control of pancreas and liver gene expression by HNF transcription factors. Science. 2004, 303 (5662): 1378-1381. 10.1126/science.1089769.CrossRefPubMedPubMedCentral
3.
go back to reference Pontoglio M, Barra J, Hadchouel M, Doyen A, Kress C, Bach JP, Babinet C, Yaniv M: Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell. 1996, 84 (4): 575-585. 10.1016/S0092-8674(00)81033-8.CrossRefPubMed Pontoglio M, Barra J, Hadchouel M, Doyen A, Kress C, Bach JP, Babinet C, Yaniv M: Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell. 1996, 84 (4): 575-585. 10.1016/S0092-8674(00)81033-8.CrossRefPubMed
4.
go back to reference Shih DQ, Bussen M, Sehayek E, Ananthanarayanan M, Shneider BL, Suchy FJ, Shefer S, Bollileni JS, Gonzalez FJ, Breslow JL, et al: Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism. Nat Genet. 2001, 27 (4): 375-382. 10.1038/86871.CrossRefPubMed Shih DQ, Bussen M, Sehayek E, Ananthanarayanan M, Shneider BL, Suchy FJ, Shefer S, Bollileni JS, Gonzalez FJ, Breslow JL, et al: Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism. Nat Genet. 2001, 27 (4): 375-382. 10.1038/86871.CrossRefPubMed
5.
go back to reference Lee YH, Sauer B, Gonzalez FJ: Laron dwarfism and non-insulin-dependent diabetes mellitus in the Hnf-1alpha knockout mouse. Mol Cell Biol. 1998, 18 (5): 3059-3068.CrossRefPubMedPubMedCentral Lee YH, Sauer B, Gonzalez FJ: Laron dwarfism and non-insulin-dependent diabetes mellitus in the Hnf-1alpha knockout mouse. Mol Cell Biol. 1998, 18 (5): 3059-3068.CrossRefPubMedPubMedCentral
6.
go back to reference Edmondson HA, Henderson B, Benton B: Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med. 1976, 294 (9): 470-472. 10.1056/NEJM197602262940904.CrossRefPubMed Edmondson HA, Henderson B, Benton B: Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med. 1976, 294 (9): 470-472. 10.1056/NEJM197602262940904.CrossRefPubMed
7.
go back to reference Bluteau O, Jeannot E, Bioulac-Sage P, Marques JM, Blanc JF, Bui H, Beaudoin JC, Franco D, Balabaud C, Laurent-Puig P, et al: Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat Genet. 2002, 32 (2): 312-315. 10.1038/ng1001.CrossRefPubMed Bluteau O, Jeannot E, Bioulac-Sage P, Marques JM, Blanc JF, Bui H, Beaudoin JC, Franco D, Balabaud C, Laurent-Puig P, et al: Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat Genet. 2002, 32 (2): 312-315. 10.1038/ng1001.CrossRefPubMed
8.
go back to reference Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S, Bacq Y, Leteurtre E, Paradis V, Michalak S, et al: Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology. 2006, 43 (3): 515-524. 10.1002/hep.21068.CrossRefPubMed Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S, Bacq Y, Leteurtre E, Paradis V, Michalak S, et al: Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology. 2006, 43 (3): 515-524. 10.1002/hep.21068.CrossRefPubMed
9.
go back to reference Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Sa Cunha A, Rullier A, Cubel G, Couchy G, Imbeaud S, et al: Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology. 2007, 46 (3): 740-748. 10.1002/hep.21743.CrossRefPubMed Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Sa Cunha A, Rullier A, Cubel G, Couchy G, Imbeaud S, et al: Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology. 2007, 46 (3): 740-748. 10.1002/hep.21743.CrossRefPubMed
10.
go back to reference Rebouissou S, Amessou M, Couchy G, Poussin K, Imbeaud S, Pilati C, Izard T, Balabaud C, Bioulac-Sage P, Zucman-Rossi J: Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature. 2009, 457 (7226): 200-204. 10.1038/nature07475.CrossRefPubMed Rebouissou S, Amessou M, Couchy G, Poussin K, Imbeaud S, Pilati C, Izard T, Balabaud C, Bioulac-Sage P, Zucman-Rossi J: Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature. 2009, 457 (7226): 200-204. 10.1038/nature07475.CrossRefPubMed
11.
go back to reference Nault JC, Fabre M, Couchy G, Pilati C, Jeannot E, Van Nhieu JT, Saint-Paul MC, De Muret A, Redon MJ, Buffet C, et al: GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation. J Hepatol. 2011 Nault JC, Fabre M, Couchy G, Pilati C, Jeannot E, Van Nhieu JT, Saint-Paul MC, De Muret A, Redon MJ, Buffet C, et al: GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation. J Hepatol. 2011
12.
go back to reference Pilati C, Amessou M, Bihl MP, Balabaud C, Nhieu JT, Paradis V, Nault JC, Izard T, Bioulac-Sage P, Couchy G, et al: Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas. J Exp Med. 2011, 208 (7): 1359-1366. 10.1084/jem.20110283.CrossRefPubMedPubMedCentral Pilati C, Amessou M, Bihl MP, Balabaud C, Nhieu JT, Paradis V, Nault JC, Izard T, Bioulac-Sage P, Couchy G, et al: Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas. J Exp Med. 2011, 208 (7): 1359-1366. 10.1084/jem.20110283.CrossRefPubMedPubMedCentral
13.
go back to reference Bacq Y, Jacquemin E, Balabaud C, Jeannot E, Scotto B, Branchereau S, Laurent C, Bourlier P, Pariente D, de Muret A, et al: Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation. Gastroenterology. 2003, 125 (5): 1470-1475. 10.1016/j.gastro.2003.07.012.CrossRefPubMed Bacq Y, Jacquemin E, Balabaud C, Jeannot E, Scotto B, Branchereau S, Laurent C, Bourlier P, Pariente D, de Muret A, et al: Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation. Gastroenterology. 2003, 125 (5): 1470-1475. 10.1016/j.gastro.2003.07.012.CrossRefPubMed
14.
go back to reference Flejou JF, Barge J, Menu Y, Degott C, Bismuth H, Potet F, Benhamou JP: Liver adenomatosis. An entity distinct from liver adenoma?. Gastroenterology. 1985, 89 (5): 1132-1138.CrossRefPubMed Flejou JF, Barge J, Menu Y, Degott C, Bismuth H, Potet F, Benhamou JP: Liver adenomatosis. An entity distinct from liver adenoma?. Gastroenterology. 1985, 89 (5): 1132-1138.CrossRefPubMed
15.
go back to reference Reznik Y, Dao T, Coutant R, Chiche L, Jeannot E, Clauin S, Rousselot P, Fabre M, Oberti F, Fatome A, et al: Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families. J Clin Endocrinol Metab. 2004, 89 (3): 1476-1480. 10.1210/jc.2003-031552.CrossRefPubMed Reznik Y, Dao T, Coutant R, Chiche L, Jeannot E, Clauin S, Rousselot P, Fabre M, Oberti F, Fatome A, et al: Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families. J Clin Endocrinol Metab. 2004, 89 (3): 1476-1480. 10.1210/jc.2003-031552.CrossRefPubMed
16.
go back to reference Jeannot E, Mellottee L, Bioulac-Sage P, Balabaud C, Scoazec JY, Tran Van Nhieu J, Bacq Y, Michalak S, Buob D, Laurent-Puig P, et al: Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage. Diabetes. 2010, 59 (7): 1836-1844. 10.2337/db09-1819.CrossRefPubMedPubMedCentral Jeannot E, Mellottee L, Bioulac-Sage P, Balabaud C, Scoazec JY, Tran Van Nhieu J, Bacq Y, Michalak S, Buob D, Laurent-Puig P, et al: Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage. Diabetes. 2010, 59 (7): 1836-1844. 10.2337/db09-1819.CrossRefPubMedPubMedCentral
17.
go back to reference Pelletier L, Rebouissou S, Paris A, Rathahao-Paris E, Perdu E, Bioulac-Sage P, Imbeaud S, Zucman-Rossi J: Loss of hepatocyte nuclear factor 1alpha function in human hepatocellular adenomas leads to aberrant activation of signaling pathways involved in tumorigenesis. Hepatology. 2010, 51 (2): 557-566.CrossRefPubMed Pelletier L, Rebouissou S, Paris A, Rathahao-Paris E, Perdu E, Bioulac-Sage P, Imbeaud S, Zucman-Rossi J: Loss of hepatocyte nuclear factor 1alpha function in human hepatocellular adenomas leads to aberrant activation of signaling pathways involved in tumorigenesis. Hepatology. 2010, 51 (2): 557-566.CrossRefPubMed
18.
go back to reference Rebouissou S, Imbeaud S, Balabaud C, Boulanger V, Bertrand-Michel J, Terce F, Auffray C, Bioulac-Sage P, Zucman-Rossi J: HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation. J Biol Chem. 2007, 282 (19): 14437-14446. 10.1074/jbc.M610725200.CrossRefPubMed Rebouissou S, Imbeaud S, Balabaud C, Boulanger V, Bertrand-Michel J, Terce F, Auffray C, Bioulac-Sage P, Zucman-Rossi J: HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation. J Biol Chem. 2007, 282 (19): 14437-14446. 10.1074/jbc.M610725200.CrossRefPubMed
19.
go back to reference Rebouissou S, Vasiliu V, Thomas C, Bellanne-Chantelot C, Bui H, Chretien Y, Timsit J, Rosty C, Laurent-Puig P, Chauveau D, et al: Germline hepatocyte nuclear factor 1alpha and 1beta mutations in renal cell carcinomas. Hum Mol Genet. 2005, 14 (5): 603-614. 10.1093/hmg/ddi057.CrossRefPubMed Rebouissou S, Vasiliu V, Thomas C, Bellanne-Chantelot C, Bui H, Chretien Y, Timsit J, Rosty C, Laurent-Puig P, Chauveau D, et al: Germline hepatocyte nuclear factor 1alpha and 1beta mutations in renal cell carcinomas. Hum Mol Genet. 2005, 14 (5): 603-614. 10.1093/hmg/ddi057.CrossRefPubMed
20.
go back to reference Kyrmizi I, Hatzis P, Katrakili N, Tronche F, Gonzalez FJ, Talianidis I: Plasticity and expanding complexity of the hepatic transcription factor network during liver development. Genes Dev. 2006, 20 (16): 2293-2305. 10.1101/gad.390906.CrossRefPubMedPubMedCentral Kyrmizi I, Hatzis P, Katrakili N, Tronche F, Gonzalez FJ, Talianidis I: Plasticity and expanding complexity of the hepatic transcription factor network during liver development. Genes Dev. 2006, 20 (16): 2293-2305. 10.1101/gad.390906.CrossRefPubMedPubMedCentral
21.
go back to reference Zhong W, Mirkovitch J, Darnell JE: Tissue-specific regulation of mouse hepatocyte nuclear factor 4 expression. Mol Cell Biol. 1994, 14 (11): 7276-7284.CrossRefPubMedPubMedCentral Zhong W, Mirkovitch J, Darnell JE: Tissue-specific regulation of mouse hepatocyte nuclear factor 4 expression. Mol Cell Biol. 1994, 14 (11): 7276-7284.CrossRefPubMedPubMedCentral
22.
go back to reference Lee JM, Dedhar S, Kalluri R, Thompson EW: The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol. 2006, 172 (7): 973-981. 10.1083/jcb.200601018.CrossRefPubMedPubMedCentral Lee JM, Dedhar S, Kalluri R, Thompson EW: The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol. 2006, 172 (7): 973-981. 10.1083/jcb.200601018.CrossRefPubMedPubMedCentral
23.
go back to reference Thiery JP: Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol. 2003, 15 (6): 740-746. 10.1016/j.ceb.2003.10.006.CrossRefPubMed Thiery JP: Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol. 2003, 15 (6): 740-746. 10.1016/j.ceb.2003.10.006.CrossRefPubMed
24.
go back to reference Thiery JP, Sleeman JP: Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 2006, 7 (2): 131-142. 10.1038/nrm1835.CrossRefPubMed Thiery JP, Sleeman JP: Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 2006, 7 (2): 131-142. 10.1038/nrm1835.CrossRefPubMed
25.
go back to reference Huber MA, Kraut N, Beug H: Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol. 2005, 17 (5): 548-558. 10.1016/j.ceb.2005.08.001.CrossRefPubMed Huber MA, Kraut N, Beug H: Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol. 2005, 17 (5): 548-558. 10.1016/j.ceb.2005.08.001.CrossRefPubMed
26.
go back to reference Coulouarn C, Factor VM, Thorgeirsson SS: Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer. Hepatology. 2008, 47 (6): 2059-2067. 10.1002/hep.22283.CrossRefPubMedPubMedCentral Coulouarn C, Factor VM, Thorgeirsson SS: Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer. Hepatology. 2008, 47 (6): 2059-2067. 10.1002/hep.22283.CrossRefPubMedPubMedCentral
27.
go back to reference Derynck R, Zhang YE: Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003, 425 (6958): 577-584. 10.1038/nature02006.CrossRefPubMed Derynck R, Zhang YE: Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003, 425 (6958): 577-584. 10.1038/nature02006.CrossRefPubMed
28.
go back to reference Billings PC, Whitbeck JC, Adams CS, Abrams WR, Cohen AJ, Engelsberg BN, Howard PS, Rosenbloom J: The transforming growth factor-beta-inducible matrix protein (beta)ig-h3 interacts with fibronectin. J Biol Chem. 2002, 277 (31): 28003-28009. 10.1074/jbc.M106837200.CrossRefPubMed Billings PC, Whitbeck JC, Adams CS, Abrams WR, Cohen AJ, Engelsberg BN, Howard PS, Rosenbloom J: The transforming growth factor-beta-inducible matrix protein (beta)ig-h3 interacts with fibronectin. J Biol Chem. 2002, 277 (31): 28003-28009. 10.1074/jbc.M106837200.CrossRefPubMed
29.
go back to reference Yamagata K, Nammo T, Moriwaki M, Ihara A, Iizuka K, Yang Q, Satoh T, Li M, Uenaka R, Okita K, et al: Overexpression of dominant-negative mutant hepatocyte nuclear fctor-1 alpha in pancreatic beta-cells causes abnormal islet architecture with decreased expression of E-cadherin, reduced beta-cell proliferation, and diabetes. Diabetes. 2002, 51 (1): 114-123.CrossRefPubMed Yamagata K, Nammo T, Moriwaki M, Ihara A, Iizuka K, Yang Q, Satoh T, Li M, Uenaka R, Okita K, et al: Overexpression of dominant-negative mutant hepatocyte nuclear fctor-1 alpha in pancreatic beta-cells causes abnormal islet architecture with decreased expression of E-cadherin, reduced beta-cell proliferation, and diabetes. Diabetes. 2002, 51 (1): 114-123.CrossRefPubMed
30.
go back to reference Sakaguchi T, Gu X, Golden HM, Suh E, Rhoads DB, Reinecker HC: Cloning of the human claudin-2 5'-flanking region revealed a TATA-less promoter with conserved binding sites in mouse and human for caudal-related homeodomain proteins and hepatocyte nuclear factor-1alpha. J Biol Chem. 2002, 277 (24): 21361-21370. 10.1074/jbc.M110261200.CrossRefPubMed Sakaguchi T, Gu X, Golden HM, Suh E, Rhoads DB, Reinecker HC: Cloning of the human claudin-2 5'-flanking region revealed a TATA-less promoter with conserved binding sites in mouse and human for caudal-related homeodomain proteins and hepatocyte nuclear factor-1alpha. J Biol Chem. 2002, 277 (24): 21361-21370. 10.1074/jbc.M110261200.CrossRefPubMed
31.
go back to reference Koffler LD, Fernstrom MJ, Akiyama TE, Gonzalez FJ, Ruch RJ: Positive regulation of connexin32 transcription by hepatocyte nuclear factor-1alpha. Arch Biochem Biophys. 2002, 407 (2): 160-167. 10.1016/S0003-9861(02)00488-5.CrossRefPubMed Koffler LD, Fernstrom MJ, Akiyama TE, Gonzalez FJ, Ruch RJ: Positive regulation of connexin32 transcription by hepatocyte nuclear factor-1alpha. Arch Biochem Biophys. 2002, 407 (2): 160-167. 10.1016/S0003-9861(02)00488-5.CrossRefPubMed
32.
go back to reference Bach I, Mattei MG, Cereghini S, Yaniv M: Two members of an HNF1 homeoprotein family are expressed in human liver. Nucleic Acids Res. 1991, 19 (13): 3553-3559. 10.1093/nar/19.13.3553.CrossRefPubMedPubMedCentral Bach I, Mattei MG, Cereghini S, Yaniv M: Two members of an HNF1 homeoprotein family are expressed in human liver. Nucleic Acids Res. 1991, 19 (13): 3553-3559. 10.1093/nar/19.13.3553.CrossRefPubMedPubMedCentral
33.
go back to reference De Simone V, De Magistris L, Lazzaro D, Gerstner J, Monaci P, Nicosia A, Cortese R: LFB3, a heterodimer-forming homeoprotein of the LFB1 family, is expressed in specialized epithelia. EMBO J. 1991, 10 (6): 1435-1443.PubMedPubMedCentral De Simone V, De Magistris L, Lazzaro D, Gerstner J, Monaci P, Nicosia A, Cortese R: LFB3, a heterodimer-forming homeoprotein of the LFB1 family, is expressed in specialized epithelia. EMBO J. 1991, 10 (6): 1435-1443.PubMedPubMedCentral
34.
go back to reference Tomassetti A, De Santis G, Castellano G, Miotti S, Mazzi M, Tomasoni D, Van Roy F, Carcangiu ML, Canevari S: Variant HNF1 modulates epithelial plasticity of normal and transformed ovary cells. Neoplasia. 2008, 10 (12): 1481-1492. 1483p following 1492CrossRefPubMedPubMedCentral Tomassetti A, De Santis G, Castellano G, Miotti S, Mazzi M, Tomasoni D, Van Roy F, Carcangiu ML, Canevari S: Variant HNF1 modulates epithelial plasticity of normal and transformed ovary cells. Neoplasia. 2008, 10 (12): 1481-1492. 1483p following 1492CrossRefPubMedPubMedCentral
35.
go back to reference Nieto MA: The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol. 2002, 3 (3): 155-166.CrossRefPubMed Nieto MA: The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol. 2002, 3 (3): 155-166.CrossRefPubMed
36.
go back to reference Peinado H, Portillo F, Cano A: Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol. 2004, 48 (5-6): 365-375. 10.1387/ijdb.041794hp.CrossRefPubMed Peinado H, Portillo F, Cano A: Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol. 2004, 48 (5-6): 365-375. 10.1387/ijdb.041794hp.CrossRefPubMed
37.
go back to reference Santangelo L, Marchetti A, Cicchini C, Conigliaro A, Conti B, Mancone C, Bonzo JA, Gonzalez FJ, Alonzi T, Amicone L, et al: The stable repression of mesenchymal program is required for hepatocyte identity: A novel role for hepatocyte nuclear factor 4alpha. Hepatology. 2011 Santangelo L, Marchetti A, Cicchini C, Conigliaro A, Conti B, Mancone C, Bonzo JA, Gonzalez FJ, Alonzi T, Amicone L, et al: The stable repression of mesenchymal program is required for hepatocyte identity: A novel role for hepatocyte nuclear factor 4alpha. Hepatology. 2011
38.
go back to reference Kuo CJ, Conley PB, Chen L, Sladek FM, Darnell JE, Crabtree GR: A transcriptional hierarchy involved in mammalian cell-type specification. Nature. 1992, 355 (6359): 457-461. 10.1038/355457a0.CrossRefPubMed Kuo CJ, Conley PB, Chen L, Sladek FM, Darnell JE, Crabtree GR: A transcriptional hierarchy involved in mammalian cell-type specification. Nature. 1992, 355 (6359): 457-461. 10.1038/355457a0.CrossRefPubMed
39.
go back to reference Bailly A, Spath G, Bender V, Weiss MC: Phenotypic effects of the forced expression of HNF4 and HNF1alpha are conditioned by properties of the recipient cell. J Cell Sci. 1998, 111 (Pt 16): 2411-2421.PubMed Bailly A, Spath G, Bender V, Weiss MC: Phenotypic effects of the forced expression of HNF4 and HNF1alpha are conditioned by properties of the recipient cell. J Cell Sci. 1998, 111 (Pt 16): 2411-2421.PubMed
40.
go back to reference Ktistaki E, Talianidis I: Modulation of hepatic gene expression by hepatocyte nuclear factor 1. Science. 1997, 277 (5322): 109-112. 10.1126/science.277.5322.109.CrossRefPubMed Ktistaki E, Talianidis I: Modulation of hepatic gene expression by hepatocyte nuclear factor 1. Science. 1997, 277 (5322): 109-112. 10.1126/science.277.5322.109.CrossRefPubMed
41.
go back to reference Battle MA, Konopka G, Parviz F, Gaggl AL, Yang C, Sladek FM, Duncan SA: Hepatocyte nuclear factor 4alpha orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver. Proc Natl Acad Sci USA. 2006, 103 (22): 8419-8424. 10.1073/pnas.0600246103.CrossRefPubMedPubMedCentral Battle MA, Konopka G, Parviz F, Gaggl AL, Yang C, Sladek FM, Duncan SA: Hepatocyte nuclear factor 4alpha orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver. Proc Natl Acad Sci USA. 2006, 103 (22): 8419-8424. 10.1073/pnas.0600246103.CrossRefPubMedPubMedCentral
42.
go back to reference Spath GF, Weiss MC: Hepatocyte nuclear factor 4 provokes expression of epithelial marker genes, acting as a morphogen in dedifferentiated hepatoma cells. J Cell Biol. 1998, 140 (4): 935-946. 10.1083/jcb.140.4.935.CrossRefPubMedPubMedCentral Spath GF, Weiss MC: Hepatocyte nuclear factor 4 provokes expression of epithelial marker genes, acting as a morphogen in dedifferentiated hepatoma cells. J Cell Biol. 1998, 140 (4): 935-946. 10.1083/jcb.140.4.935.CrossRefPubMedPubMedCentral
43.
go back to reference Kanazawa T, Ichii O, Otsuka S, Namiki Y, Hashimoto Y, Kon Y: Hepatocyte Nuclear Factor 4 Alpha Is Associated with Mesenchymal-Epithelial Transition in Developing Kidneys of C57BL/6 Mice. J Vet Med Sci. 2010 Kanazawa T, Ichii O, Otsuka S, Namiki Y, Hashimoto Y, Kon Y: Hepatocyte Nuclear Factor 4 Alpha Is Associated with Mesenchymal-Epithelial Transition in Developing Kidneys of C57BL/6 Mice. J Vet Med Sci. 2010
44.
go back to reference Gotzmann J, Fischer AN, Zojer M, Mikula M, Proell V, Huber H, Jechlinger M, Waerner T, Weith A, Beug H, et al: A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes. Oncogene. 2006, 25 (22): 3170-3185. 10.1038/sj.onc.1209083.CrossRefPubMed Gotzmann J, Fischer AN, Zojer M, Mikula M, Proell V, Huber H, Jechlinger M, Waerner T, Weith A, Beug H, et al: A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes. Oncogene. 2006, 25 (22): 3170-3185. 10.1038/sj.onc.1209083.CrossRefPubMed
45.
go back to reference Cicchini C, Filippini D, Coen S, Marchetti A, Cavallari C, Laudadio I, Spagnoli FM, Alonzi T, Tripodi M: Snail controls differentiation of hepatocytes by repressing HNF4alpha expression. J Cell Physiol. 2006, 209 (1): 230-238. 10.1002/jcp.20730.CrossRefPubMed Cicchini C, Filippini D, Coen S, Marchetti A, Cavallari C, Laudadio I, Spagnoli FM, Alonzi T, Tripodi M: Snail controls differentiation of hepatocytes by repressing HNF4alpha expression. J Cell Physiol. 2006, 209 (1): 230-238. 10.1002/jcp.20730.CrossRefPubMed
46.
go back to reference Heldin CH, Landstrom M, Moustakas A: Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol. 2009, 21 (2): 166-176. 10.1016/j.ceb.2009.01.021.CrossRefPubMed Heldin CH, Landstrom M, Moustakas A: Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol. 2009, 21 (2): 166-176. 10.1016/j.ceb.2009.01.021.CrossRefPubMed
47.
go back to reference Inagaki Y, Okazaki I: Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis. Gut. 2007, 56 (2): 284-292. 10.1136/gut.2005.088690.CrossRefPubMedPubMedCentral Inagaki Y, Okazaki I: Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis. Gut. 2007, 56 (2): 284-292. 10.1136/gut.2005.088690.CrossRefPubMedPubMedCentral
48.
go back to reference Lemaigre FP: Mechanisms of liver development: concepts for understanding liver disorders and design of novel therapies. Gastroenterology. 2009, 137 (1): 62-79. 10.1053/j.gastro.2009.03.035.CrossRefPubMed Lemaigre FP: Mechanisms of liver development: concepts for understanding liver disorders and design of novel therapies. Gastroenterology. 2009, 137 (1): 62-79. 10.1053/j.gastro.2009.03.035.CrossRefPubMed
49.
go back to reference Clotman F, Lemaigre FP: Control of hepatic differentiation by activin/TGFbeta signaling. Cell Cycle. 2006, 5 (2): 168-171. 10.4161/cc.5.2.2341.CrossRefPubMed Clotman F, Lemaigre FP: Control of hepatic differentiation by activin/TGFbeta signaling. Cell Cycle. 2006, 5 (2): 168-171. 10.4161/cc.5.2.2341.CrossRefPubMed
Metadata
Title
HNF1α inhibition triggers epithelial-mesenchymal transition in human liver cancer cell lines
Authors
Laura Pelletier
Sandra Rebouissou
Danijela Vignjevic
Paulette Bioulac-Sage
Jessica Zucman-Rossi
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2011
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-11-427

Other articles of this Issue 1/2011

BMC Cancer 1/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine